John Phillips, MD
Interventional Cardiology · Columbus, OHNPI 1922120732
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (51.2%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 23.6%. Among interventional cardiology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 642 payments — averaging $638.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cook Incorporated$97K
- Johnson & Johnson$69K
- Philips North America LLC$65K
- Boston Scientific$50K
- Abbott$42K
- Bard Peripheral Vascular, Inc.$24K
- plus $63K from 25 others
Across 50 payments — averaging $4183.16 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Shockwave Medical, Inc$164K
- Boston Scientific$21K
- Medtronic$16K
- M.a. Med Alliance S.A.$6K
- Cardiovascular Systems Inc.$3K
- Bard Peripheral Vascular, Inc.$300
What the payments were for
- Consulting fees$144,82335%
- Speaking & faculty fees$209,90651%
- Travel & lodging$34,0388%
- Food & beverage$21,4455%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cook Incorporated | 48 | $97,007 |
| Johnson & Johnson | 56 | $69,193 |
| Philips North America LLC | 60 | $64,809 |
| Boston Scientific | 78 | $50,284 |
| Abbott | 90 | $42,035 |
| Bard Peripheral Vascular, Inc. | 28 | $23,764 |
| Cook Medical LLC | 84 | $13,666 |
| Venturemed Group, Inc. | 17 | $12,292 |
| Medtronic(2 entities) | 42 | $9,664 |
| Reflow Medical Inc | 11 | $6,283 |
| Cagent Vascular Inc | 5 | $5,964 |
| Cardiovascular Systems Inc. | 59 | $3,855 |
| Siemens Medical Solutions USA, Inc. | 15 | $3,528 |
| Shockwave Medical, Inc | 5 | $3,086 |
| Inari Medical, Inc. | 10 | $1,801 |
| Angiodynamics, Inc. | 7 | $665 |
| W. L. Gore & Associates, Inc. | 6 | $416 |
| Avinger Inc. | 6 | $408 |
| Corindus Inc. | 1 | $394 |
| ZOLL Circulation Inc | 1 | $150 |
| Gilead | 1 | $147 |
| Endologix LLC | 1 | $129 |
| Teleflex LLC | 1 | $126 |
| Mercator Medsystems, Inc. | 1 | $123 |
| Penumbra, Inc. | 1 | $122 |
| Organogenesis Inc. | 1 | $106 |
| Biocompatibles, Inc. | 1 | $84 |
| Stryker | 2 | $55 |
| Edwards Lifesciences | 2 | $29 |
| Imperative Care, Inc | 1 | $15 |
| Cardinal Health 200 LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARELTO$68,544
- ESPRIT$40,250
- (9520) IGT Devices Undivided$33,956
- Zilver PTX$29,195
- Micropuncture$27,558
- GENERAL - THERAPIES$13,237
- Cook Medical IAA$11,943
- Cook Medical Zilver PTX$11,004
- AngioJet XMI$11,000
- FLEX Scoring Catheter$10,895
- (8334) Image Guided Therapy Devices _ Peripheral$9,737
- LUTONIX$8,835
- Zilver Vena$6,069
- (R11) US EQ Undivided$6,000
- GENERAL VASCULAR INTERVENTION$5,686
- Serrantor$5,600
- ANGIOJET$5,000
- (6554) Peripheral Vascular Undivided$4,858
- Cook Medical Self-Expanding Stent$4,400
- FlowMet$4,200
How this compares
$410,212 in reported general payments places this provider in the 95th percentile of 256 interventional cardiology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 104 | $78,504 |
| EliquisApixaban | 41 | $45,873 |
| ClopidogrelClopidogrel Bisulfate | 301 | $2,357 |
| Atorvastatin Calcium | 101 | $973 |
| Cilostazol | 73 | $799 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 95 | $646 |
| Metoprolol Succinate | 50 | $466 |
| Ezetimibe | 22 | $219 |
| Lisinopril | 39 | $215 |
| Rosuvastatin Calcium | 27 | $210 |
| Losartan Potassium | 29 | $179 |
| Carvedilol | 21 | $82 |
| Amlodipine Besylate | 18 | $57 |
| Hydrochlorothiazide | 19 | $44 |
| Metoprolol Tartrate | 37 | $35 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $69,193 | $78,504104 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 256 interventional cardiology providers in Ohio.
Other interventional cardiology in Columbus
- Gary AnselColumbus$3.3M
- John CheathamColumbus$1.4M
- Carlos Sanchez SotoColumbus$1.1M
- Steven YakubovColumbus$907K
- Mitchell SilverColumbus$562K
- Michael JollyColumbus$281K
- Timothy SmithColumbus$149K
- Christopher HuffColumbus$119K
- Joseph CampbellColumbus$114K
- Aref AmroColumbus$62K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.